CCR9 [7E7] Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-CCR9 [7E7] antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCCR9 [7E7]
Clone[7E7]
Host SpeciesRat
Reactive Speciesmouse. predicted to work with human
IsotypeIgG2b
Formatunconjugated
Size1 mL
Concentration20ug/ml
ApplicationsImmunocytochemistry (ICC), Immunofluorescence (IF), Flow Cytometry (FC/FACS), Immunohistochemistry (IHC) Formalin
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
Descriptionn/a
ImmunogenImmunogen: Synthetic peptide: PTDFTSPIPNMADDYGSEST, corresponding to N terminal amino acids 3-22 of Mouse CCR9
Other Names[Chemokine (C-C motif) receptor 9 isoform A; Chemokine (C-C motif) receptor 9 isoform B; CC chemokine receptor D6; C C chemokine receptor type 9; C C CKR 9; CC Chemokinereceptor CCR10; CC CKR 9; CCBP2; CCCKR9; CCR 9; CCR9; CDw199; CDw199 antigen; Chemokine (C C motif) receptor 9, isoform CRA_a; Chemokine C C motif receptor 9; Chemokine C C receptor 10; Chemokine CC Motif Receptor9; Chemokine receptor CCR 9; Chemokine receptor CCR9; Chemokine-binding protein D6; Cmkbr10; CMKBR9; G protein coupled receptor 28; GPR 28; GPR 9 6; GPR28; GPR96; OTTHUMP00000164653; OTTHUMP00000164654], [CCR9; CCR9; GPR28; CDw199; GPR-9-6; CC-CKR-9; GPR28; C-C CKR-9; CC-CKR-9; CCR-9]
Gene, Accession #[CCR9], Gene ID: 10803, NCBI: NP_006632.2, UniProt: P51686
Catalog #MBS375122
Price$415
Order / More InfoCCR9 [7E7] Antibody from MYBIOSOURCE INC.
Product Specific ReferencesPabst O et al. Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine. J Exp Med 199:411-6 (2004) PMID: 14744993
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.